Cross-Border M&A Activity in Pharmaceutical & Healthcare Industry -





Summary 

GlobalData's “Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry - Q3 2011” report is an essential source of data and trend analysis on cross border mergers and acquisitions (M&As) and asset transactions in the pharmaceuticals industry. The report provides detailed information on cross border and domestic M&As and asset transactions registered in the pharmaceuticals industry in Q3 2011. The report provides detailed comparative data on the number of deals and their value in the last five quarters segregated into domestic and cross border transactions.  

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research. 

Scope 

- Analysis of the cross border M&A trends for the pharmaceutical industry in the global arena.
- Analysis of M&As and asset transactions in the pharmaceutical industry.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
 

Reasons to buy 

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing regions for investments in your industry.
- Identify companies that are aggressively looking to acquire companies in operating in your industry
- Do deals with an understanding of how competitors are involving in mergers and acquisitions that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
 
 

  

  

1 Table of Contents
1 Table of Contents 1
1.1 List of Tables 1
1.2 List of Figures 1
2 M&A Deals: Cross-Border Acquistions Decline In Recent Times 2
2.1 Pharmaceuticals & Healthcare, Global, Cross-Border Acquisitions, Number of Deals, Q3 2011 2
2.2 Pharmaceuticals & Healthcare, Global, Cross-Border Acquisitions, Deal Values, Q3 2011 4
2.3 Pharmaceuticals & Healthcare, Global, Number of Acquisition Deals, Q3 2011 6
2.4 Pharmaceuticals & Healthcare, Global, Acquisition Deals By Deal Values, Q3 2011 8
2.5 Pharmaceuticals & Healthcare, Global Mergers, Q3 2011 10
3 Further Information 11
3.1 Methodology 11
3.2 About GlobalData 11
3.3 Contact Us 12
3.4 Disclosure information 12
3.5 Disclaimer 12
 

List of Tables 

Table 1: Pharmaceuticals & Healthcare, Global, Cross-Border Acquisitions, Number of Deals, Q3 2010 - Q3 2011 3
Table 2: Pharmaceuticals & Healthcare, Global, Cross-Border Acquisition Deals By Deal Values (US$m), Q3 2010 - Q3 2011 5
Table 3: Pharmaceuticals & Healthcare, Global, Number of Acquisition Deals, Q3 2010 - Q3 2011 7
Table 4: Pharmaceuticals & Healthcare, Global, Acquisition Deals By Deal Values (US$m), Q3 2010 - Q3 2011 9
Table 5: Pharmaceuticals & Healthcare, Global Mergers, Q3 2010 - Q3 2011 10
 

1.2 List of Figures 

Figure 1: Pharmaceuticals & Healthcare, Global, Cross-Border Acquisitions, Number of Deals, Q3 2010 - Q3 2011 2
Figure 2: Pharmaceuticals & Healthcare, Global, Cross-Border Acquisitions, Deal Values, Q3 2010 - Q3 2011 4
Figure 3: Pharmaceuticals & Healthcare, Global, Number of Acquisition Deals, Q3 2010 - Q3 2011 6
Figure 4: Pharmaceuticals & Healthcare, Global, Acquisition Deals By Deal Values (US$m), Q3 2010 - Q3 2011 8
Figure 5: Pharmaceuticals & Healthcare, Global Mergers, Q3 2010 - Q3 2011 10